Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
AZ's COPD drug cuts flare-ups in two phase 3 trials
AstraZeneca’s experimental COPD drug has significantly reduced flare-ups in two late-stage trials, making FDA approval in 2027 now possible.
11 Sep 2026
Daily Movement Behaviors Can Significantly Lower Cancer Risk
Reallocating daily movement behaviors from sedentary habits toward standing or active motion significantly lowers cancer incidence.
11 Sep 2026
New MASH Drug Reduces Liver Fat in Phase 2 Trial
An experimental drug significantly reduced liver fat after 12 weeks in adults with MASH in a phase 2 clinical trial.
11
Mins
11 Sep 2026
Where is the Future of Diabetes Treatment Heading? Interview with David M. Nathan
The major studies I have participated in have all been collegial, collaborative efforts. I helped lead some of…
AbbVie drug meets phase 3 goal in menstrual migraine
AbbVie’s atogepant has met the primary endpoint of its phase 3 trial, which tested the drug as a preventive treatment for menstrual migraine.
11 Sep 2026
Why Orexin in Alzheimer Disease Demands Targeted Sleep Therapy
Elevated orexin in Alzheimer disease accelerates cognitive decline, but synchronized sleep rhythms provide vital neural protection.
11 Sep 2026
High Myopia Shows Distinct 3D Remodelling Trajectories
A 15-year MRI study identified five high myopia globe remodelling trajectories, with focal deformation associated with greater macular and tractional complications.
11 Sep 2026
Improving Outcomes for Haemato-Oncology Patients
This educational video features a dynamic expert debate revisiting the important aspects of empirical versus pre-emptive antifungal…
10 Sep 2026
Recent COVID-19 Tripled Some Bacteremia Mortality Rates
Staphylococcus aureus bacteremia mortality rose during the COVID-19 pandemic, particularly among hospital-onset cases with recent infection.
10 Sep 2026
How E-Cigarette Exposure May Reshape Fetal Lung Immunity
Prenatal e-cigarette exposure may disrupt fetal lung immunity and increase newborn susceptibility to respiratory viral infections.
←
1
2
3
…
25
26
27
28
29
30
31
…
1,782
1,783
1,784
→
We’ve noticed you’re accessing
from
North/South America.
View
View